Connect with us

Health

PharmAccess and Bank of Industry partner with Nigeria’s Delta State to revitalize 25 healthcare facilities

Published

on

Delta State in Southern Nigeria has implemented Medical Credit Fund’s innovative Access to Finance Framework as part of its overall renovation of primary health centers throughout the state. It involves utilizing Public-Private Partnership as a method to delivering quality health services at local levels, particularly those in rural or hard to reach areas where a majority of the poor reside. The partnership is between Delta State Government, the Bank of Industry and PharmAccess Group, through its non-profit health fund, Medical Credit Fund, dedicated to health SMEs in Africa.

The scheme supports the outsourcing of defunct and abandoned healthcare facilities to the private sector to revitalize and provide services to the enrollees of the state’s health insurance scheme – especially in the rural areas. In addition, through a matching fund arrangement between the Bank of Industry and the State Government, the private sector players would have access to loans with concessionary interest rates to renovate these facilities. Medical Credit Fund provides partial guarantees to the Lenders on the loans they give to the private sector facilties in addition to business development support to ensure sustainability. The facilities are also quality assured through the adoption of PharmAccess’ SafeCare methodology.

Ms. Njide Ndili the Country Director of PharmAccess Foundation in Nigeria stated that “Medical Credit Fund is focused on developing innovative models to include the private sector to maximize efficiency and access to existing Primary Healthcare Centers anchored on health insurance”. She added that the Access to Finance scheme was very important to make funds available to the private sector partners with Delta State in achieving quality and affordable healthcare for Deltans through the contributory health insurance scheme.

Dr. Olamide Okulaja, Director Advocacy and Communications at PharmAccess in Nigeria said the State displayed a pragmatic approach to solving the issues the plaguing Primary Healthcare levels in the country. He further stated that with less than 5,000 out of over 24,000 Primary health facilities functional in the country, this framework may represent a way of providing a vibrant supply side to the demand-side activities springing up across the country, including the State Health Insurance Schemes and the implementation of the Basic Health Care Provision Fund.

Source: PharmAccess Foundation

Health

Amref Health Africa Kenya Partners with Sisu Global Health and Surgipharm to improve access to blood

Published

on

By

Nairobi, Kenya, 17 September 2019 – Amref Health Africa in Kenya, Sisu Global Health and Surgipharm have today unveiled a partnership to improve access to blood and safer surgical outcomes during medical missions and emergencies in Kenya.

The partnership is aimed at increasing blood access in all hospitals to reduce internal bleeding-related deaths through the adoption of HemafuseTM, an innovative medical device that allows clinicians to reuse a patient’s own blood gathered from internal bleeding.

This initiative comes in the wake of the recent move by the US President’s Emergency Plan for AIDS Relief (PEPFAR) to stop its annual funding of KShs2 billion for blood collection and testing services in Kenya. This development comes at a time when the country is facing a chronic shortage of blood as the collection of blood has been plagued by the lack of funds for screening tools and human resources to collect and store blood.

“Blood access is critical to safe surgery. Standard surgical practices require two units of blood on-hand before surgery commences, but there is a severe shortage of blood in the country. Surgeries may be delayed or not performed due to a lack of blood, resulting in increased illness and death. This partnership will make use of an innovative solution that will ensure that patients with internal bleeding have a chance of survival,” said Amref Health Africa in Kenya’s Country Director, Dr Meshack Ndirangu.

HemafuseTM, a product by Sisu Global Health, can filter and pump blood from an internal haemorrhage into a blood bag, allowing it to be re-transfused to the same patient. The device can also be reused up to 25 times. This provides an alternative to donor blood.

“It is inspiring to see Hemafuse used to save lives. With this partnership with Kenya, we look forward to enabling thousands of more clinicians to save more lives across the country. The work we are doing is incredibly important and we are proud to have such a strong partnership with Amref to provide access to blood across Kenya,” said Sajju Jain, Chief Operating Officer at Sisu Global Health.

Also Read Prioritizing A Traditionally Underserved Somaliland Population Over Profit – Adan Abbey

Speaking at the event, Mr Rakesh Vinayak, Director-Sales & Marketing at Surgipharm, said that the pharmaceutical industry has a critical role to play in finding effective and sustainable solutions to providing access to today’s most pressing health concerns. “Surgipharm has a highly specialised and experienced management team and our relationships with different players in Kenya’s health sector complements and strengthens our existing skill set in logistics across the country. We are excited about the prospects that this partnership brings.”

Amref Health Africa

Continue Reading

Health

Memfys Hospital and GE Healthcare Collaborate to Improve Disease Diagnosis for Nigeria’s South-East Regions

Published

on

By

Memfys is the first hospital in South-East Nigeria to install GE Healthcare’s SIGNA™ Explorer 1.5Tesla MRI system

LAGOS, Nigeria, August 29, 2019 – The collaboration will help provide innovative technology to enable early diagnosis and detection of diseases; Memfys is the first hospital in South-East Nigeria to install GE Healthcare’s SIGNA™ Explorer 1.5Tesla MRI system.

GE Healthcare has partnered with Memfys Hospital to provide the SIGNA™ Explorer 1.5Tesla MRI system services and training to advance early diagnosis of diseases. By providing clinicians with detailed information about diseases such as cancer, neurological disorders and heart diseases, the new equipment will help the hospital to deliver high quality medical services and better care to more patients across the region.

As the only dedicated Neurosurgery hospital in South-East Nigeria, Memfys Hospital is serving a population of over 60 Million People. Investing in the latest technologies such as the SIGNA™ Explorer 1.5Tesla MRI system will help improve the hospital’s diagnostic capabilities for early detection of diseases and at the same time keep up with global best practices to provide the very best for the country and West Africa region at large.

“As a leader in the neurosurgical space, we are committed to continue providing high quality patient care using modern, high tech and reliable equipment that meets the recommendation by the World Federation of Neurosurgical Societies (WFNS). Acquisition of the SIGNA™ Explorer is a huge milestone towards this commitment,” said Professor Samuel C. Ohaegbulam, CEO Global Memfys & Co Ltd.

To ensure sustainability of such investments, Memfys hospital is providing training for both young and experienced doctors embarking on a career in Neurosurgery and Spinal surgery. The hospital is accredited by the West African College of Surgeons (WACS) for full training in neurosurgery making it the only private health institution to enjoy this status in all of Africa. To date, Memfys has trained 20 neurosurgeons and about 10 senior residents.

“We are committed to continue collaborating with both private and public partners to co-create solutions that help tackle pressing healthcare challenges for our region such as Noncommunicable diseases (NCDs), as we strive towards Universal Health Coverage. With the SIGNA™ Explorer 1.5Tesla MRI system, the people of South-East Nigeria will not need to leave the region for such specialized services as it has been the practice in the past,” said Eyong Ebai, General Manager for West & Central and French Sub-Sahara Africa Region.

Also Read Lebohang Lebogo: First generation drone pilot delivering blood for SANBS

According to WHO’s 2018 report, NCDS including stroke, cardiovascular diseases, cancers, chronic respiratory diseases  and diabetes are estimated to account for 71% of the 57 million global deaths, while in Nigeria NCDs are estimated to account for 29% of all deaths (2.1M). Early diagnosis of diseases such as cancer improves outcomes by providing care at the earliest possible stage.

– GE.

Continue Reading

Health

Egypt denies postponing official launch of health insurance system

Published

on

By

Hala Zayed, Minister of Health Pic: Egypt Today

CAIRO – 29 August 2019: Egypt denied delaying the official launch of the comprehensive health insurance system in Port Said, which is scheduled for the first half of coming Septwmbwe, due to failure of teh pilot phase, according to the cabinet’s media center.

Ministry of Health confirmed that the effective implementation of the system will start in the first half of September, especially after the success of the pilot, the center added in a statement.

Earlier in August, President Abdel Fatah al-Sisi called for implementing the health insurance system, taking into consideration the technical, human and medical sides to ensure the good quality of medical services.

Also Read Lebohang Lebogo: First generation drone pilot delivering blood for SANBS

In July, the pilot operation of the comprehensive health insurance system in Port Said governorate started in July.

Prime Minister Mostafa Madbouly said earlier in a press conference that the governorate will be the first to benefit from the new system through 11 general and specialized hospitals and 32 healthcare units.

– Egypt Today 

Continue Reading

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 1,797 other subscribers

Ads

Most Viewed